SCHEMBL7918498

SCHEMBL7918498

Cc1nc(-c2ccc(NC(=O)c3ccc(F)cc3F)nc2)c(C(C)C)s1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NTRK1 P04629 2/20 0.45
▸ ABCB1 P08183 1/20 0.44
▸ ABL1 P00519 2/20 0.43
▸ PIK3C3 Q8NEB9 3/20 0.43
▸ KDM4E B2RXH2 3/20 0.42
▸ NPC1 O15118 3/20 0.42
▸ RAB9A P51151 3/20 0.42
▸ ALDH1A1 P00352 2/20 0.42
▸ TP53 P04637 1/20 0.42
▸ GLA P06280 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ GRM5 P41594 4/20 0.41
▸ NTRK2 Q16620 1/20 0.41
▸ TRPV1 Q8NER1 1/20 0.41
▸ MAPK1 P28482 1/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ HTR1F P30939 1/20 0.40
▸ DGAT1 O75907 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13321615 0.90 ABCB1 (0.44) NTRK1ABCB1ABL1PIK3C3KDM4E
SCHEMBL7918495 0.89 ABCB1 (0.43) NTRK1ABCB1ABL1PIK3C3KDM4E
SCHEMBL7933347 0.84 ABCB1 (0.51) ABCB1GAAGRM5
SCHEMBL2849853 0.84 GPR55 (0.44) ABCB1GRM5MAPK1HTR1F
SCHEMBL13640667 0.71 KDM4E (0.52) ABCB1KDM4ENPC1RAB9AALDH1A1
SCHEMBL7918493 0.70 KDM4E (0.46) ABCB1KDM4ENPC1RAB9AALDH1A1
SCHEMBL5232592 0.70 HCAR3 (0.57) ABCB1KDM4ENPC1RAB9AALDH1A1
SCHEMBL7924155 0.70 KDM4E (0.45) ABCB1KDM4ENPC1RAB9AALDH1A1
SCHEMBL13321619 0.70 KDM4E (0.45) ABCB1KDM4ENPC1RAB9AALDH1A1
SCHEMBL5835414 0.69 CDK2 (0.57) KDM4ENPC1RAB9AALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010039237-A1 COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2010-04-08 — — WO disclosed
Send feedback